Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT07143552
Recruiting Observational

Bone Outcomes, Obesity, Sunlight, and Trauma in Children

NCT07143552 · tracked via the Priya Life Science Italy tracker
Sponsor
Paracelsus Medical University
Phase
Observational
Started
2024-07-01
Last updated
2025-09-03

Condition(s) studied

Pediatric FracturesHypovitaminosis DObesity and Overweight

Study summary

Prospective case-control study of children (3-15 years) after low-energy trauma. We compare serum bone metabolic markers (25OHD, PTH, ALP, calcium, phosphate), BMI/percentile, and dietary calcium intake between fracture and non-fracture presentations. Blood is collected within 7 days (non-fasting; samples on ice for PTH). Primary aim: association of ALP and calcium with fracture status; secondary aims: vitamin D status, BMI percentile, and a composite Bone Risk Score (≥3). Analyses: group comparisons, logistic regression, ROC.

Eligibility

Sex
ALL
Min age
3 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 3-15 years; * low-energy trauma; * cases = radiographic fracture; controls = no fracture. Exclusion Criteria: * chronic renal/liver disease; * primary hypo-/hyperparathyroidism; * hypophosphatemic rickets; * neuromuscular disorders; * corticosteroids/bisphosphonates; * unclear diagnosis/treatment.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Kaiser Franz Joseph Hospital Brixen Bolzano Recruiting
Franz Tappeiner Hospital Meran Bolzano Recruiting

Other trials for the same condition

Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity Recruiting
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project Starting soon
Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital Recruiting
Reprogramming Energy Homeostasis in Overweight Individuals Via Exercise, Cognitive, and Social Training Recruiting
Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07143552 on ClinicalTrials.gov ↗ ← All trials in Italy